Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Adults With Fatigue Associated With Major Depressive Disorder
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy, safety and tolerability of
Levomilnacipran ER for the treatment of fatigue associated with major depressive disorder
(MDD).